test

ANDREW TIMPSON

@Silverarc Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters

Portfolio positions

This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BNTXBiontech Se
Recent Activity
New Position
0.7%
$3.098M
26,083 shares@ $118.78 avg price
GPCRStructure Therapeutics Inc
Recent Activity
0.7%
$3.095M
70,516 shares@ $43.89 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
0.67%
$2.968M
419,242 shares@ $7.08 avg price
TELATela Bio Inc
Recent Activity
Increased 12.5%
0.64%
$2.846M
1.125M shares@ $2.54 avg price
CGENCompugen Ltd
Recent Activity
0.62%
$2.717M
1.501M shares@ $1.82 avg price
CERSCerus Corp
Recent Activity
Increased 2.02%
0.59%
$2.602M
1.495M shares@ $1.74 avg price
ZVRAZevra Therapeutics Inc
Recent Activity
New Position
0.55%
$2.429M
350,000 shares@ $6.94 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Decreased -35.39%
0.51%
$2.243M
167,986 shares@ $13.35 avg price
BIOABioage Labs Inc
Recent Activity
New Position
0.47%
$2.08M
100,000 shares@ $20.8 avg price
UNCYUnicycive Therapeutics Inc
Recent Activity
New Position
0.37%
$1.632M
4M shares@ $0.41 avg price